| scholarly article | Q13442814 |
| P356 | DOI | 10.3892/OR.2013.2318 |
| P953 | full work available online at | https://europepmc.org/articles/PMC3658864 |
| https://europepmc.org/articles/PMC3658864?pdf=render | ||
| https://spandidos-publications.com/10.3892/or.2013.2318/download | ||
| https://www.spandidos-publications.com/or/29/5/1701/download | ||
| P932 | PMC publication ID | 3658864 |
| P698 | PubMed publication ID | 23467634 |
| P5875 | ResearchGate publication ID | 235881719 |
| P2093 | author name string | Dan Hu | |
| Fuxiang Chen | |||
| Qingqiong Luo | |||
| Dongxia Ye | |||
| Shuiqing Hu | |||
| Zujun Sun | |||
| P2860 | cites work | SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia | Q24299542 |
| SUMO modification of the Ets-related transcription factor ERM inhibits its transcriptional activity | Q24300888 | ||
| The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing | Q24312057 | ||
| SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation | Q24328747 | ||
| SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1 | Q24563640 | ||
| Role of desumoylation in the development of prostate cancer | Q24676101 | ||
| Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation | Q27647348 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. | Q27863917 | ||
| The SUMO-specific protease SENP5 is required for cell division | Q27863924 | ||
| Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3 | Q28145507 | ||
| SUMO: a history of modification | Q28243325 | ||
| A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase | Q28509495 | ||
| SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress | Q33800141 | ||
| Ubiquitin-like proteins: new wines in new bottles | Q33901542 | ||
| Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. | Q34337304 | ||
| Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors | Q34380370 | ||
| Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases | Q34392520 | ||
| Oral cancer and precancerous lesions | Q34525597 | ||
| Blood iron, glutathione, and micronutrient levels and the risk of oral cancer | Q36460688 | ||
| A review of betel quid chewing, oral cancer and precancer in Mainland China | Q36720258 | ||
| SUMO on the road to neurodegeneration | Q36809376 | ||
| Transient global cerebral ischemia induces a massive increase in protein sumoylation | Q40120643 | ||
| Global shifts in protein sumoylation in response to electrophile and oxidative stress. | Q40479648 | ||
| The World Oral Health Report 2003: continuous improvement of oral health in the 21st century--the approach of the WHO Global Oral Health Programme | Q40525523 | ||
| Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways | Q42834927 | ||
| Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation | Q43725106 | ||
| Increased protein SUMOylation following focal cerebral ischemia. | Q46908369 | ||
| Oral Cancer | Q56603649 | ||
| The SUMO protease SENP5 is required to maintain mitochondrial morphology and function | Q56907347 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oral squamous cell carcinoma | Q18553522 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 1701-1706 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Oncology Reports | Q7092098 |
| P1476 | title | Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation | |
| P478 | volume | 29 |
| Q26864235 | Advances in the development of SUMO specific protease (SENP) inhibitors |
| Q37581632 | Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro |
| Q48447452 | Expression and cell distribution of SENP3 in the cerebral cortex after experimental subarachnoid hemorrhage in rats: a pilot study |
| Q61445872 | Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma |
| Q91783063 | Nuclear Nrf2 Activity in Laryngeal Carcinoma is Regulated by SENP3 After Cisplatin-Induced Reactive Oxygen Species Stress |
| Q99551758 | PLAC8 inhibits oral squamous cell carcinogenesis and epithelial-mesenchymal transition via the Wnt/β-catenin and PI3K/Akt/GSK3β signaling pathways |
| Q39108925 | SUMO and the robustness of cancer |
| Q38260216 | SUMO-specific proteases/isopeptidases: SENPs and beyond |
| Q26776081 | SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer |
| Q42648308 | Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation |
| Q39017134 | Targeting nuclear thymidylate biosynthesis |
| Q55514789 | The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis. |
Search more.